However, in INCL and LINCL secondary to mutated CLN2 — the most severe forms in terms of signs/symptoms at onset, disease progression and survival — the majority of mutations predicted severe loss of function. This evidence concerns the gene TPP1 and infantile neuronal ceroid lipofuscinosis.